Can the active ingredient in magic mushrooms help treat anxiety? Researchers want to know

Press/Media: Public Engagement Activities

Description

Australia is embarking on one of the world’s largest studies into the use of psychedelic drugs for mental health, with Melbourne researchers preparing to launch a world-first clinical trial investigating whether psilocybin – the active ingredient in "magic mushrooms" – can help treat people suffering severe persistent anxiety.

A second trial will assess the role of MDMA – "ecstasy" – in helping patients with intractable post-traumatic stress disorder.

Period8 Dec 2020

Media contributions

1

Media contributions

  • TitleCan the active ingredient in magic mushrooms help treat anxiety? Researchers want to know
    Media name/outletThe Age
    Media typePrint
    Country/TerritoryAustralia
    Date8/12/20
    DescriptionAustralia is embarking on one of the world’s largest studies into the use of psychedelic drugs for mental health, with Melbourne researchers preparing to launch a world-first clinical trial investigating whether psilocybin – the active ingredient in "magic mushrooms" – can help treat people suffering severe persistent anxiety.

    A second trial will assess the role of MDMA – "ecstasy" – in helping patients with intractable post-traumatic stress disorder.
    Producer/AuthorKate Cole-Adams
    URLhttps://www.theage.com.au/national/victoria/can-the-active-ingredient-in-magic-mushrooms-help-treat-anxiety-researchers-want-to-know-20201206-p56kyx.html
    PersonsPaul Liknaitzky
View all 1
View less